Validity and reliability of the TED-QOL: A new three-item questionnaire to assess quality of life in thyroid eye disease

British Journal of Ophthalmology

Volumn 95, Issue 12, 2011, Pages 1670-1674

  Fayers, Tessa ^a   Dolman, Peter J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDOCRINE OPHTHALMOPATHY; EYE INFLAMMATION; EYE MOVEMENT DISORDER; FEMALE; GRAVES OPHTHALMOPATHY QUALITY OF LIFE SCALE; HUMAN; INSTRUMENT VALIDATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RELIABILITY; SCORING SYSTEM; STRABISMUS; THYROID EYE DISEASE QUALITY OF LIFE; VALIDATION PROCESS; VISUAL IMPAIRMENT;

DISEASE PROGRESSION; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; MALE; PILOT PROJECTS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 81555205831     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-300487     Document Type: Article

References (14)

1. Terwee CB, Gerding MN, Dekker FW, et al. Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. Br J Ophthalmol 1998;82:773-9. (Pubitemid 28376907)
2. Yeatts RP. Quality of life in patients with Graves ophthalmopathy. Trans Am Ophthalmol Soc 2005;103:368-411.
3. Dolman PJ, Rootman J. VISA classification for Graves orbitopathy. Ophthal Plast Reconstr Surg 2006;22:319-24. (Pubitemid 44434337)
4. EORTC Quality of Life Group. Guidelines for developing questionnaire modules. 3rd rev edn. European Organisation for Research and Treatment of Cancer (EORTC), Brussels; 2002.
5. Fayers PM, Machin D. Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. Chichester: John Wiley & Sons, 2007.
6. Graves' Ophthalmopathy. Quality of life questionnaire GO-QOL version UK 1. 1999. Obtained through personal correspondence with Terwee CB.
7. Terwee CB, Gerding MN, Dekker FW, et al. Testeretest reliability of the GO-QOL: a disease-specific quality of life questionnaire for patients with Graves'ophthalmology. J Clin Epidemiol 1999;52:875-84. (Pubitemid 29385601)
8. Elberling TV, Rasmussen AK, Feldt-Rasmussen U, et al. Impaired health-related quality of life in Graves' disease. A prospective study. Eur J Endocrinol 2004;151:549-55. (Pubitemid 39562508)
9. Kahaly GJ, Petrak F, Hardt J, et al. Psychosocial morbidity of Graves' orbitopathy. Clin Endocrinol (Oxf) 2005;63:395-402. (Pubitemid 41442333)
10. Kulig G, Andrysiak-Mamos E, Sowińska-Przepiera E, et al. Quality of life assessment in patients with Graves' disease and progressive infiltrative ophthalmopathy during combined treatment with methylprednisolone and orbital radiotherapy. Endokrynol Pol 2009;60:158-65.
11. Lee H, Roh HS, Yoon JS, et al. Assessment of quality of life and depression in Korean patients with Graves' ophthalmopathy. Korean J Ophthalmol 2010;24:65-72.
12. Gerding MN, Terwee CB, Dekker FW, et al. Quality of life in patients with Graves'ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid 1997;7:885-9. (Pubitemid 28041663)
13. Bradley EA, Sloan JA, Novotny PJ, et al. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy. Ophthalmology 2006;113:1450-4. (Pubitemid 44108178)
14. de Boer AG, van Lanschot JJ, Stalmeier PF, et al. Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res 2004;13:311-20. (Pubitemid 38392259)